Literature DB >> 2555239

Banting lecture 1989. Structure and function of insulin receptors.

O M Rosen1.   

Abstract

The actions of insulin are mediated by an integral plasma membrane protein, the insulin receptor. The processed receptor is a tetramer composed of two alpha-subunits that bind insulin and two beta-subunits that traverse the plasma membrane and are, in their cytosolic domains, protein tyrosine kinases. The insulin proreceptor cDNA has been cloned and its complete amino acid sequence deduced. The availability of cDNA permitted an analysis of both the role of protein tyrosine kinase activity in insulin action and the autophosphorylation sites that regulate kinase activity. The human cDNA probe has also been used to identify a putative Drosophila insulin receptor. This work is reviewed, and approaches that may be used to identify physiological substrates for the receptor kinase are suggested.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2555239     DOI: 10.2337/diab.38.12.1508

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  7 in total

1.  Immunocytochemical localisation of insulin receptors on rat superior cervical ganglion neurons in dissociated cell culture.

Authors:  S James; N J Patel; P K Thomas; G Burnstock
Journal:  J Anat       Date:  1993-02       Impact factor: 2.610

2.  Colocalisation of insulin and IGF-1 receptors in cultured rat sensory and sympathetic ganglion cells.

Authors:  S N Karagiannis; R H King; P K Thomas
Journal:  J Anat       Date:  1997-10       Impact factor: 2.610

3.  The hypophyseal pars tuberalis is enriched with distinct phosphotyrosine-containing proteins not detected in other areas of the brain and pituitary.

Authors:  J W Unger; A M Moss; J N Livingston
Journal:  Cell Tissue Res       Date:  1993-06       Impact factor: 5.249

4.  Cytoskeletal components enhance the autophosphorylation of retinal insulin receptor.

Authors:  Raju V S Rajala; Ammaji Rajala
Journal:  Chem Biol Interact       Date:  2009-03-31       Impact factor: 5.192

5.  2-(3,4-Dihydro-2H-pyrrolium-1-yl)-3oxoindan-1-olate (DHPO), a novel, synthetic small molecule that alleviates insulin resistance and lipid abnormalities.

Authors:  Machender R Kandadi; Prabhakar K Rajanna; Mazhuvancherry K Unnikrishnan; Sai P Boddu; Yinan Hua; Ji Li; Min Du; Jun Ren; Nair Sreejayan
Journal:  Biochem Pharmacol       Date:  2010-02-15       Impact factor: 5.858

Review 6.  Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms.

Authors:  Biagio Arcidiacono; Stefania Iiritano; Aurora Nocera; Katiuscia Possidente; Maria T Nevolo; Valeria Ventura; Daniela Foti; Eusebio Chiefari; Antonio Brunetti
Journal:  Exp Diabetes Res       Date:  2012-06-04

7.  New target genes for the peroxisome proliferator-activated receptor-γ (PPARγ) antitumour activity: Perspectives from the insulin receptor.

Authors:  Daniela P Foti; Francesco Paonessa; Eusebio Chiefari; Antonio Brunetti
Journal:  PPAR Res       Date:  2009-06-29       Impact factor: 4.964

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.